KORU Medical Systems, Inc. (KRMD) |
| 4.95 0.03 (0.61%) 02-26 16:00 |
| Open: | 4.92 |
| High: | 4.98 |
| Low: | 4.89 |
| Volume: | 56,101 |
| Market Cap: | 229(M) |
| PE Ratio: | -61.87 |
| Exchange: | NASDAQ Capital Market |
| Industry: | Medical - Instruments & Supplies |
| Sector: | Healthcare |
| Technical analysis | ||||
![]() |
||||
| sell | buy | |||
| Resistance 2: | 5.84 |
| Resistance 1: | 5.26 |
| Pivot price: | 4.74 |
| Support 1: | 4.31 |
| Support 2: | 3.58 |
| 52w High: | 6.608 |
| 52w Low: | 1.86 |
KORU Medical Systems, Inc. designs, manufactures, and markets portable medical devices primarily for the ambulatory infusion market in the United States and internationally. It offers mechanical infusion product comprising the FREEDOM infusion systems that include the FREEDOM60 syringe driver, the FreedomEdge syringe driver, HIgH-Flo subcutaneous safety needle sets, and precision flow rate tubing. The company also provides education and training materials to clinicians, patients, and patient advocates. It sells its products through direct sales and medical device distributors, as well as online. KORU Medical Systems, Inc. was incorporated in 1980 and is headquartered in Chester, New York.
| EPS | -0.080 |
| Book Value | 0.360 |
| PEG Ratio | 0.00 |
| Gross Profit | 0.526 |
| Profit Margin (%) | -9.50 |
| Operating Margin (%) | -8.34 |
| Return on Assets (ttm) | -9.2 |
| Return on Equity (ttm) | -21.7 |
Fri, 27 Feb 2026
KORU Medical Systems to Report Fourth Quarter and Full Year 2025 Financial Results on March 12, 2026 - BioSpace
Fri, 13 Feb 2026
Topline fund reports 8.5% KORU Medical stake (NASDAQ: KRMD) - Stock Titan
Thu, 12 Feb 2026
Down 18.1% in 4 Weeks, Here's Why KORU Medical Systems, Inc. (KRMD) Looks Ripe for a Turnaround - Yahoo Finance
Fri, 06 Feb 2026
Is There An Opportunity With KORU Medical Systems, Inc.'s (NASDAQ:KRMD) 49% Undervaluation? - simplywall.st
Tue, 03 Feb 2026
KORU Medical Systems, Inc. (KRMD) Soars 5.6%: Is Further Upside Left in the Stock? - Yahoo Finance
Thu, 29 Jan 2026
KORU Medical Systems Receives FDA 510(k) Clearance for Delivery of RYSTIGGO® (rozanolixizumab-noli), Expanding Label for FreedomEDGE® Infusion System - Business Wire
|
StockChart iOS |
StoxlineLite iOS |
StoxlineLite iOS |
OptionCalc iOS |
|
StockChart Android |
StoxlineLite Android |
StoxlinePro Android |
OptionCalc Android |